BUZZ-U.S. Stocks on the Move-Ambit, Athlon, Tonix, Tibco, Amag

lunes 29 de septiembre de 2014 08:48 GYT

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter,; for the Morning News Call newsletter,

U.S. stock index futures are pointing to a solidly lower open on Monday, but if recent trends hold, investors may use the decline as an opportunity to add to positions. Dow Jones industrial average futures were down 0.63 percent at 16,922, S&P 500 futures were down 0.68 percent at 1,962.5 and Nasdaq 100 futures were down 0.72 percent at 4,016.75.

** AMBIT BIOSCIENCES CORP, Friday close $8.2, +87.44 pct premarket

The drugmaker said Daiichi Sankyo Co Ltd will buy the company for $410 million, or $15 per share in cash. The company said the deal includes Ambit's lead blood cancer drug, quizartinib, which is currently in late-stage studies.

** TIBCO SOFTWARE INC, Friday close $19.51, +21.22 pct premarket

The business software maker said buyout firm Vista Equity Partners had agreed to take it private for $4.3 billion.